Adaptogens refer to the plant-based substances such as herbs used to help the human body manage stress, anxiety, fatigue, and overall wellbeing. Adaptogens are added to food or beverages or consumed as tinctures. The main types of adaptogens by nature are organic and synthetic. The organic adaptogens are naturally produced from plants or herbs such as ashwagandha, astragalus, eleuthero, holy basil, jiaogulan, turmeric, cordyceps, and others. Organic adaptogens do not use any chemicals and fertilizers during their farming. Adaptogens are sourced from ashwagandha, ginseng, astragalus, holi basil, rhodiola rosea, schisandra, adaptogenic mushrooms and others and distributed through online and offline sales channel. These are used in food and beverages, dietary and sports supplements, pharmaceutical, cosmetics and animal feed. The adaptogens market research report is one of a series of new reports from The Business Research Company that provides adaptogens market statistics, including adaptogens industry global market size, regional shares, competitors with an adaptogens market share, detailed adaptogens market segments, market trends and opportunities, and any further data you may need to thrive in the adaptogens industry. This adaptogens market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global adaptogens market size grew from $9.79 billion in 2022 to $10.7 billion in 2023 at a compound annual growth rate (CAGR) of 9.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The adaptogens market size is expected to grow to $15.37 billion in 2027 at a CAGR of 9.5%. The rising demand for healthy food and beverages is expected to propel the growth of the adaptogens market. Increasing health consciousness among the global population is driving the demand for healthy food and beverages. Healthy foods and beverages with rich nutrients are needed to maintain the body's health and energy levels. Adaptogens help the body respond to stress, anxiety, fatigue, and overall well-being. The rising demand for healthy food and beverages will create demand for adaptogens that which are an essential component of healthy food and beverages due to their herbal properties. For instance, according to the Food & Health survey 2021 by the Internation Food Information Council, a US-based nonprofit organization for food, beverage, and agricultural industries, approximately 85% of Americans claimed that the pandemic had caused them to adjust their diet or cooking habits in some way and additionally, 60% of Americans simply try to eat healthily, whereas 20% actively seek out items or adhere to diets for certain health benefits. In addition, according to the American multinational food processing and commodities trading corporation ADM, during the pandemic, 18% of Americans bought their first plant-based protein products and 51% of people were looking to adopt products that help them maintain a healthy weight. Thus, the rising demand for healthy food and beverages will drive the adaptogens market. The adaptogen drink is a key trend gaining popularity in the adaptogens market. Adaptogen drink is a beverage made with adaptogens that are all-natural botanical ingredients with healing properties. The adaptogens are potential ingredients that counterattack the effects of stress, anxiety, and fatigue and promote healing. Adaptogen drink is made like a regular drink with whole fruit juices, organic adaptogens, and aromatherapeutic superfoods. Adaptogen drink is a new trend due to their excellent uses such as instant energy-boosting, fast replacement to tea and coffee, soothing nighttime drink, and other health benefits. It is an essential drink for people with low mental energy or high mental or physical fatigue. Key companies are focusing on developing and offering adaptogen drinks to attract customers, increase business and gain a competitive edge in the market by leveraging all the benefits of adaptogens. For instance, Rebbl, a US-based beverage company has developed and provides adaptogen beverages in indulgent flavors. These lines of beverages are produced with a mixture of adaptogens such as ashwagandha, super herbs, low sugar content, organic coconut sugar, and stevia extract with no gums, thickeners, or artificial flavors. These beverages include herbs such as ashwagandha, maca, moringa, matcha, and reishi with functional benefits. The company has developed these adaptogen beverages to target customers that are health-conscious and offer the ability to stabilize physiological processes and promote homeostasis. In July 2021, Constellation Brands Inc., a US-based producer, and marketer of beer, wine, and spirits acquired a minority stake in HOP WTR, for an undisclosed amount. With this acquisition, Constellation Brands adds a new portfolio to its business and expands its offerings with adaptogen-based non-alcoholic sparkling beverages. HOP WTR is a US-based provider of non-alcoholic, calorie-free sparkling beverages infused with adaptogens and nootropics. Major players in the adaptogens market are REBBL, Nutra Industries Inc., Organic India, Xian Yuensun Biological Technology Co. Ltd., PLT Health Solutions Inc., Xi’an Greena Biotech Co. Ltd., Amax NutraSource Inc., NutraCap Labs, Changsha Organic Herb Inc., Organic Herb Inc., Nutra Science Labs and Organika Health Products Inc. North America was the largest region in the adaptogens market in 2022. The regions covered in the adaptogens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the adaptogens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The adaptogens market consists of sales of alkaloids, terpenoids, flavonoids, and coumarins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global adaptogens market is segmented - 1) By Nature: Organic, Synthetic 2) By Source: Ashwagandha, Ginseng, Astragalus, Holi Basil, Rhodiola Rosea, Schisandra, Adaptogenic mushrooms, Other Sources 3) By Distribution Channel: Online, Offline 4) By Application: Food And Beverages, Dietary And Sports Supplements, Pharmaceutical, Cosmetics, Animal Feed

The compost refers to a mixture that is used for fertilizing, enhancing soil structure, offering a variety of nutrients to plants, and increasing the number of helpful bacteria in the soil. Compost can be manufactured artificially by creating ideal environment for composting by regulating the aerobic, biological breakdown of biodegradable materials. The main products of compost are yard trimming, food waste, manure, mushroom compost, and vermicomposting. The yard trimming is made from discarded grass, leaves, and tree and brush trimmings from residential, institutional, and commercial sources. It is also made by chopping woody stalks and twigs with a shovel or machete or run them over with a lawn mower or through a shredder. The application of compost include agriculture, home gardening, landscaping, horticulture, construction, and other applications. The compost market research report is one of a series of new reports from The Business Research Company that provides compost market statistics, including compost industry global market size, regional shares, competitors with a compost market share, detailed compost market segments, market trends and opportunities, and any further data you may need to thrive in the compost industry. This compost market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global compost market size grew from $6.82 billion in 2022 to $7.4 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The compost market size is expected to grow to $9.51 billion in 2027 at a CAGR of 6.5%. The increasing demand for organic farm products is propelling the growth of the compost market. Organic farm products are grown without synthetic insecticides, growth hormones, antibiotics, chemical fertilizers, and synthetic pesticides. The demand for organic food increased during the COVID-19 epidemic as people are more inclined toward the consumption of foods that are healthier and better for immunity. Moreover, organic products are regarded as being of a high caliber and as being safer for the environment and human health. Organic farming widely utilizes compost to increase the fertility of the soil. For instance, in September 2021, the National Institute of Food and Agriculture (NIFA), a division of the U.S. Department of Agriculture (USDA), announced an investment of more than $30 million for 33 grants to help farmers and ranchers who cultivate and sell high-quality organic food, fiber, and other organic goods. Therefore, increasing demand for organic farm products is expected to boost the demand for compost during the forecast period. Strategic partnership is a key trend gaining popularity in the compost market. Companies and organizations are entering into a partnership with compost manufacturing companies and service providers to use agricultural and domestic waste in a better way. In August 2021, the city of Durango in Colorado, United States entered into a public-private partnership with Table to Farm Compost. Through this partnership, Durango and Table to Farm will boost voluntary curbside composting participation through education and outreach programs. The city will assess the feasibility of scaling up toward required participation in three to five years if education and outreach activities are successful. Table to Farm Compost is a US-based residential & commercial compost service that helps Durango households to go green. In August 2022, Synagro Technologies, Inc., a US-based provider of biosolids and waste management services, acquired Liberty Composting, Inc. The acquisition is expected to increase Synagro's organics and biosolid composting capacity in California, providing more options to the region's current and future client base. Liberty Composting, Inc. is a US-based provider of composting services for organics and biosolids. Major players in the compost market are MyNOKE, NutriSoil, Davo’s Worm Farms, Suman Vermi Compost, Wormpower, Kahariam Farms, SAOSIS, Sri Gayathri Biotec, Agrilife, Dirt Dynasty, SLO County Worm Farm, Pacific AG, Dirt Hugger, and Harvest Power. Asia-Pacific was the largest region in the compost market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the compost market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the compost market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The compost market consists of sales of anaerobic, aerobic and vermicomposting. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global compost market is segmented - 1) By Product Type: Yard Trimming, Food Waste, Manure, Mushroom Compost, Vermicomposting 2) By Application: Agriculture, Home Gardening, Landscaping, Horticulture, Construction, Other Applications

Oyster mushroom cultivation refers to the process of growing mushrooms organically on dead, decaying wood logs and occasionally on dying deciduous or coniferous wood trunks in temperate and tropical forests. Oyster mushroom can grow for 6 to 8 months of the year at a moderate temperature of 20 to 300 C and a humidity of 57% to 70%. The main forms of oyster mushroom cultivation are fresh mushrooms, frozen mushrooms, dried mushrooms, and canned mushrooms. Fresh mushrooms refer to edible fungus, which provides several important nutrients. Fresh mushrooms in the oyster mushroom cultivation market refer to oyster mushrooms that have not undergone any preservation process. The various phases include phase I – composting, phase II – spawning, phase III – casing, phase IV – pinning, and phase V – harvesting, which are used in the food processing industry, retail outlets, food services, and other applications. The oyster mushroom cultivation market research report is one of a series of new reports from The Business Research Company that provides oyster mushroom cultivation market statistics, including global oyster mushroom cultivation industry size, regional shares, competitors with an oyster mushroom cultivation market share, detailed oyster mushroom cultivation market segments, market trends and opportunities, and any further data you may need to thrive in the oyster mushroom cultivation industry. This oyster mushroom cultivation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global oyster mushroom cultivation market size grew from $2.69 billion in 2022 to $2.85 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The oyster mushroom cultivation market size is expected to grow to $3.55 billion in 2027 at a CAGR of 5.6%. An increase in the production and cultivation of mushrooms is expected to propel the growth of the oyster mushroom cultivation market going forward. Mushroom cultivation refers to the technology of growing mushrooms using plants, animals, and industrial waste. The increase in the production and cultivation of mushrooms helps to develop various varieties of mushrooms, including oyster mushrooms as well. For instance, according to the Food and Agriculture Organization, a Roam-based food specialized agency of the United Nations, in 2020, there are 99.87 billion points of mushrooms produced globally. China produced the highest quantity of mushrooms, which is 88.1 billion pounds. This was followed by Japan and the US, which produced 1.04 billion and 816 million pounds of mushrooms respectively and hold the second and third positions in mushroom production. Therefore, the increase in the production and cultivation of mushrooms is driving the growth of the oyster mushroom cultivation market. New cultivation techniques have emerged as a key trend gaining popularity in the oyster mushroom cultivation market. Major companies operating in the oyster mushroom cultivation sector are focused on developing new techniques to sustain their position in the market. For instance, in May 2022, Nuvedo, an India-based mushroom production company, launched mushroom growing kits based on cultivation technology. This mushroom kit gives a practical, low-tech, user-friendly, hands-on way for beginners to get fresh, organic mushrooms at home. In January 2021, South Mill Champs, a US-based company engaged in producing and distributing mushrooms, acquired The Mushroom Company for an undisclosed amount. Through this acquisition, South Mill Champs would expand its capabilities and product innovation, which would help them remain the industry leader. The Mushroom Company is a US-based manufacturer of mushrooms. Major players in the oyster mushroom cultivation market are Monaghan Group, Walsh Mushrooms Group, Mycelium Organic Farms Pvt Ltd., Smithy Mushrooms Ltd., Italspwan di Valentino e Massimo Sartor S.S., Luoyang Fudamei Agricultural Production Co.Ltd., Hirano Mushroom LLC, Fujishukin Co. Ltd., Greensfarm Sp. z o.o., Kalina Boczniaki, Pol Grzyb Wojciech Wizinski, Phillips Mushroom Farms, Chengde Runlong Food Co. LTD., Societa' Agricola Porretta - Le Ghiottone, Shanghai Xuerong Bio-Technology Co Ltd., and Hunan Chunhua Biotech Co. Ltd. Asian-Pacific was the largest region in the oyster mushroom cultivation market in 2022. The regions covered in the oyster mushroom cultivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the oyster mushroom cultivation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The oyster mushroom cultivation market revenues earned by entities by button mushroom, straw mushroom, and paddy mushroom. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global oyster mushroom cultivation market is segmented - 1) By Form: Fresh Mushroom, Frozen Mushroom, Dried Mushroom, Canned Mushroom 2) By Phase: Phase I - Composting, Phase Ii - Spawning, Phase Iii - Casing, Phase Iv - Pinning, Phase V - Harvesting 3) By Application: Food Processing Industry, Retail Outlets, Food Services, Other Applications

The antifungal drugs refer to drugs that are used to detect and eliminate fungal pathogens. The fungal pathogens thrive in the body in unhygienic and unclean environments. These drugs are also known as antimycotic medications, used to treat and prevent mycoses such as athlete's foot, ringworm, candidiasis (thrush), and serious systemic infections such as cryptococcal meningitis, and others. The main types of drugs in antifungals are echinocandins, azoles, polyenes, and allylamines. Echinocandins are a new type of antifungal medication that works by inhibiting the formation of 1,3-D-glucan, a key component of the fungal cell wall, in an entirely fungal-specific manner. The different routes of administration include oral, parenteral, and topical and involve various therapeutic indications such as aspergillosis, dermatophytosis, candidiasis, and others. The several sectors include hospitals and clinics, dermatology clinics, and other users. The antifungals market research report is one of a series of new reports from The Business Research Company that provides antifungals market statistics, including antifungals industry global market size, regional shares, competitors with antifungals market share, detailed antifungals market segments, market trends, and opportunities, and any further data you may need to thrive in the antifungals industry. This antifungals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global antifungals market size will grow from $31.12 billion in 2022 to $35.19 billion in 2023 at a compound annual growth rate (CAGR) of 13.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global antifungals market size is expected to grow to $54.88 billion in 2027 at a CAGR of 11.8%. A point prevalence survey was conducted in Turkey. According to the survey, antifungal drugs were mostly prescribed in pediatrichematology and oncology (PHO) units (35.2%), followed by neonatal ICUs (NICUs) (19.6%). The other units prescribing antifungal drugs included pediatric services (18.3%), pediatric ICUs (PICUs) (14.6%), and hematopoietic (HSCT) units (7.3%). According to the same survey, the antifungals were used for prophylaxis in 48.8% of patients and about 50% of patients were treated with antifungal drugs based on observation. Among 50% of patients, who were treated post-observation, around 18.8% of patients have prescribed an antifungal therapy, and 31.2% of patients were targeted for the treatments. The increasing prevalence of fungal infections is expected to propel the growth of the antifungals market. Diseases such as SARS, Zika virus, Ebola and COVID-19 have increasingly led to infections in various parts of the world, leading to an increase in the global disease burden. According to the World Health Organization (WHO), in 2022, over the course of the COVID-19 pandemic, the number of fungal infections increased markedly amongst hospitalized patients. In addition, according to a 2022 article published in British weekly scientific journal, Nature, there was a spike in invasive Candida infections in patients with COVID-19 in the intensive care units (ICUs) of Wuhan, China. Additionally, during the second wave of the pandemic, India reported more than 47,500 cases of COVID-19 associated mucormycosis between May and August 2021. Hence, the increasing incidence of fungal infections is expected to drive the market in the forecast period. Antifungal drug manufacturers are offering skimming prices for branded drugs. The discovery, development, and manufacturing processes of branded drugs generally require high investments. As a result, companies in the market offer branded drugs at the highest initial prices and implement other pricing strategies to ensure the product stays competitive at a high price. Price skimming is a pricing strategy in which a company charges a high initial price and then gradually lowers the price to attract more price-sensitive customers. It is used to maximize profits when a new product is introduced in the market. Manufacturers and marketers of branded drugs should consider adopting the price skimming strategy for branded drugs. They should price these branded drugs high to recover the high costs incurred during drug development and manufacturing. Drug developers and manufacturers are scaling up the various departments such as research and development, marketing, and manufacturing through collaborations and strategic partnerships with other companies and research institutes, to expand their product portfolios. So, companies in the anti-infective drugs market should consider strategic collaborations to broaden their scope and product portfolios to increase revenues and stay competitive in the market. Major players in the antifungals market are Pfizer, Novartis, Merck & Co., Bayer Healthcare and Abbott Laboratories, Sanofi-Aventis, Kramer Laboratories, GlaxoSmithKline Gilead, Enzon Pharmaceuticals Inc., and Basilea Pharmaceuticals AG. North America was the largest region in the drugs for antifungals market in 2022. The Middle East is expected to be the fastest-growing region in the global antifungals market. The regions covered in the global antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the antifungals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The antifungal market consists of sales of clotrimazole, miconazole, and ketoconazole. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global antifungals market is segmented - 1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines 2) End users: Hospitals & Clinics, Dermatology clinics, Other Users 3) By Route of Administration: Oral, Parenteral, Topical 4) By Therapeutic Indications: Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications

Fungicides are pesticides that control fungal diseases by killing or inhibiting fungi or fungal spores. Fungi can cause serious damage in agriculture, resulting in critical losses in yield, quality, and profit. Tea tree oil, cinnamaldehyde, and nimbin are examples of natural fungicides. The main types of fungicides are synthetic fungicides and bio-fungicides. Fungicides control fungal diseases by killing or inhibiting fungi or fungal spores. The active ingredients involved are dithiocarbamates, benzimidazoles, chloronitriles, triazoles, phenylamides, strobilurins, and other active ingredients that are used for seed treatment, soil treatment, foliar spray, chemigation, and post-harvest. The various applications are cereals and grains, oilseeds and pulses, fruits and vegetables, and other applications. The fungicides market research report is one of a series of new reports from The Business Research Company that provides fungicides market statistics, including fungicides industry global market size, regional shares, competitors with a fungicides market share, detailed fungicides market segments, market trends and opportunities, and any further data you may need to thrive in the fungicides industry. This fungicides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global fungicides market size will grow from $20.77 billion in 2022 to $22.11 billion in 2023 at a compound annual growth rate (CAGR) of 6.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global fungicides market size is expected to grow from $28.86 billion in 2027 at a CAGR of 6.9%. Farmers globally are adopting intensive farming techniques to increase productivity per hectare, driving the demand for pesticides and other agricultural chemicals. Intensive farming is an agricultural intensification and mechanization system that aims to maximize yields from available land through means such as heavy use of pesticides and chemical fertilizers. These techniques help to meet the rising demand for food from the growing population and prevent food shortages. Intensive farming techniques such as monoculture drive the demand for pesticides. Monoculture is the practice of growing one type of crop intensively over a large area, depleting the nutrients in the soil and making it heavily dependent on pesticides. The rising demand for organic food products is expected to negatively impact the fungicide market. This can be attributed to changing lifestyles and an increasing preference for organic food. Organic food products are derived from farming systems without the use of fungicides. According to the 2020 Organic Industry Survey released by the Organic Trade Association, U.S. organic food sales hit $50.1 billion in 2020, up 4.6% from 2019. Hence, the rising demand for organic food products will limit the use of fungicides in crop production, restricting the growth of the fungicide market. Because inorganic fungicides are less expensive than organic fungicides, they are in high demand in developing agricultural countries such as China, Brazil, and India. Other factors driving this market include rapid population growth, depleting cultivable land, lack of proper regulations, and increasing demand for quality fruits and vegetables. Inorganic fungicides are manufactured from abundantly available and easily produced elements, making the product significantly cheaper. Farmers in developing regions procuring inorganic fungicides in large quantities are expected to drive the market in the forecast period. In May 2022, UPL Limited, an Indian chemical industry company acquired OptiCHOS, a naturally-derived fungicide from BioCHOS for an undisclosed amount. UPL acquired OptiCHOS as an addition to its natural plant protection (NPP) business division. NPP will launch OptiCHOS products in the next few years. BioCHOS is a Norway-based plant protection products company. Major players in the fungicides market are Adama Agricultural Solutions Ltd., American Vanguard Corporation, BASF SE, Bayer Cropscience AG, Bioworks Inc., Dow Agrosciences LLC., DuPont, FMC Corporation, Marrone Bio Innovations Inc., and Monsanto Company. Asia-Pacific was the largest region in the fungicides market in 2022. South America was the second-largest region in the global fungicides market. The regions covered in the global fungicides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the fungicides market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The fungicides market consists of the sales of captan, folpet, dithiocarbamates, pentachlorophenol, and mercurial fungicides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global fungicides market is segmented - 1) By Type: Synthetic Fungicides, Bio-fungicides 2) By Active Ingredient: Dithiocarbamates, Benzimidazoles, Chloronitriles, Triazoles, Phenylamides, Strobilurins, Other Active Ingredients 3) By Treatment: Seed Treatment, Soil Treatment, Foliar Spray, Chemigation, Post-Harvest 4) By Application: Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, Other Applications

Digestive enzymes refer to compounds that aid in digestion by assisting with food breakdown. These proteins accelerate the chemical processes that transform food into compounds that can be absorbed by the digestive system. The salivary glands and the cells lining the stomach, pancreas, and small intestine produce (release) them. The main types of digestive enzymes are carbohydrates, protease, lipase, and other enzyme types. Lipase is a protein produced by the pancreas; a small organ located near the stomach that aids in fat digestion. The enzymes originated from animals, fungi, microbial, and plants that are used for indigestion, chronic pancreatitis, irritable bowel syndrome, and other applications. The various distribution channel includes retail stores and online stores. The digestive enzymes market research report is one of a series of new reports from The Business Research Company that provides digestive enzymes market statistics, including digestive enzymes industry global market size, regional shares, competitors with a digestive enzymes market share, detailed digestive enzymes market segments, market trends and opportunities, and any further data you may need to thrive in the digestive enzymes industry. This digestive enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global digestive enzymes market grew from $0.82 billion in 2022 to $0.89 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The digestive enzymes market is expected to grow from $1.32 billion in 2027 at a CAGR of 10.3%. The rising prevalence of the gastrointestinal disorder among different age groups drives the growth of the digestive enzymes market. Gastrointestinal disorders include disorders in the gastrointestinal tract starting from the mouth, oesophagus, stomach, small intestine, large intestine, and anus caused due to lack of digestive enzymes. Gastrointestinal disorders require the digestive enzymes to be taken orally as a dietary supplement or as a drug. The increased rates of gastrointestinal disorders are linked to smoking, diet and genetics, sanitation, increased use of antibiotics, and the changing environmental factors due to industrialization and urbanization. According to the American Gastroenterological Association’s survey published in April 2020 on the worldwide prevalence and burden of functional gastrointestinal disorders, among 73,076 adult respondents, about 40.3% of people met the diagnostic criteria for at least 1 functional gastrointestinal disorder (FGIDs). FGID was more prevalent among women than men. A large-scale multinational study found that more than 40% of the population is having FGIDs across the globe. Therefore, the increase in the prevalence of digestive diseases contributes to the growth of the market. The potential side effects of digestive enzyme supplements and drugs restrain the growth of the digestive enzymes market. Continuous intake of digestive enzymes increases dependency on the digestive enzymes resulting in a weaker digestive system over time. The weakened digestive system leads to digestive distress, gas, nausea, bloating, decreased stomach acid, and allergic reactions accompanied by diarrhea and vomiting. For instance, the digestive enzyme bromelain causes thinning of the blood and increases the risk of excess bleeding. The thinning of the blood is the result of the anti-platelet activity caused by the drug. Thus, the side effects caused by the excess and continuous intake of digestive enzymes negatively impact the growth of the digestive enzyme market. The companies in the digestive enzymes market are investing in developing customized digestive enzymes. These customized digestive enzymes are condition-specific enzymes to support digestion for digestive sensitive patients and may contain multiple enzymes in the same product. The companies involved in manufacturing digestive enzymes are developing customized digestive enzymes to ease the digestion of different types of food. For instance, Sabinsa, a USA-based provider of herbal extracts, cosmeceuticals, minerals, and dietary supplements, formulated DigeZyme. DigeZyme is a multi-enzyme complex comprising five different enzymes, namely, cellulase, lactase, amylase, lipase, and protease. It is widely used by people who have difficulty in digesting carbohydrates, fats, and proteins, respectively. The companies are increasingly investing in developing customized digestive enzymes. In January 2020, Nestlé, a Switzerland-based food and drink processing corporation, entered into an asset purchase agreement with Allergan, an Ireland-based pharmaceutical company that acquires, develops, and markets brand name drugs, to acquire Zenpep for an amount undisclosed. Through the acquisition, Nestle aims to expand its medical nutrition portfolio by including Zenpep products to support food ingestion, digestion, and absorption. Zenpep is a medication for people who cannot digest food properly due to the lack of digestive enzymes. Major players in the digestive enzymes market are Garden of Life, Biotics Research Corporation, Klaire Laboratories, Abbott Nutrition, AbbVie Inc., Allergan PLC., Johnson & Johnson Inc. Amway Corporation, Food State Inc., Matsun Nutrition, Metagenics Inc., Twinlab Corporation, Food State Inc., AST Enzymes, VEMO 99 OOD, Advanced Vital Enzymes Pvt. Ltd., Zeus Biotech Limited, Vox Nutrition Inc., Enzyme Bioscience Pvt. Ltd., Metagenics, XYMOGEN Inc., Douglas Laboratories, Thorne Research, Integrative Therapeutics LLC., Pure Encapsulations, Ortho Molecular Products Inc., Designs for Health Inc., Master Supplements Inc., and Proteozymes. North America was the largest region in the digestive enzymes market in 2022. Middle East is expected to be the largest growing region in the global digestive enzymes market during the forecast period. The regions covered in the global digestive enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the digestive enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The digestive enzymes market consists of sales of amylase, maltase, and lactase. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global digestive enzymes market is segmented - 1) By Enzyme Type: Carbohydrates, Protease, Lipase, Other Enzyme Types 2) By Origin: Animal, Fungi, Microbial, Plant 3) By Application: Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications 4) By Distribution Channel: Retail Stores, Online Stores

The pesticides and other agricultural chemicals refer to agricultural and household pest control chemicals (except fertilizers) used to control pests and weeds in farmlands. These are used to protect plants against pests, kill weeds and bugs, and get rid of diseases. The main types of pesticides and other agricultural chemicals are herbicides, insecticides, fungicides, other types of pesticides, and other agricultural chemicals. Herbicides are chemicals that are used to control undesirable vegetation. Herbicide application occurs in row-crop farming, where they are applied before or during planting to maximize crop productivity by minimizing other vegetation. The origin is synthetic and bio-based. The applications involved are grains and cereals, pulses and oilseeds, commercial crops, fruits and vegetables, and other applications. The pesticides and other agricultural chemicals market research report is one of a series of new reports from The Business Research Company that provides pesticides and other agricultural chemicals market statistics, including pesticides and other agricultural chemicals industry global market size, regional shares, competitors with a pesticides and other agricultural chemicals market share, detailed pesticides and other agricultural chemicals market segments, market trends and opportunities, and any further data you may need to thrive in the pesticides and other agricultural chemicals industry. This pesticides and other agricultural chemicals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pesticide and other agricultural chemicals market grew from $90.5 billion in 2022 to $98.42 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pesticide and other agricultural chemicals market is expected to grow to $139.42 billion in 2027 at a CAGR of 9.1%. The world population is growing and is expected to reach 10 billion by 2050. This is expected to significantly boost the pesticide and other agricultural chemicals market during the forecast period. An increase in the population creates more demand for food. Crop production, farming activities, and trade volumes will have to increase to meet the increased population. Additionally, farmers and commercial farming companies will increase acquisitions of arable land to increase crop production. This is expected to increase the demand for insecticides, herbicides, and fungicides in the forecast period. The rising demand for organic food products is expected to negatively impact the pesticide market during the forecast period. Organic food products are derived through a farming system that avoids the use of pesticides and other artificial additives. For instance, according to the Organic Trade Association, a North American business association for the organic industry, the organic food sales in the United States increased by 12.8% in 2020 to a new high of $56.4 billion. This rise in demand for organic products is likely to restrain the pesticide and other agricultural chemicals market during the forecast period. Toxicologists globally are adopting nanotechnology in the development of new, environmentally friendly insecticides. Nanoparticles have revolutionized the pharmaceutical and chemical industries. Pesticidal nanoformulations are ultrafine particles with enhanced permeability, stability, and solubility. Most engineers believe that nanotechnology can help make insecticides much safer. Nano-sized insecticides can be sprayed in lesser amounts on agricultural fields in comparison with conventional forms. For example, Lansiumamide B (antibacterial) is formulated as a nanocapsule to treat tobacco bacterial wilt. Thiamethoxam (insecticide) is sprayed as nanoscaled fiber, and Deltamethrin (insecticide) is formulated as a lipid nanoparticle. Major companies in the pesticide and other agricultural chemicals market include Syngenta AG, Bayer AG, Marubeni, Corteva Inc., Nutrien Ltd., FMC Corp, BASF SE, Adama Agricultural Solutions, Nufarm Limited, and Reckitt Benckiser Group plc. Asia-Pacific was the largest region in the pesticide and other agricultural chemicals market in 2022. Western Europe was the second largest region in the pesticide and other agricultural chemicals market. The regions covered in the pesticides and other agricultural chemicals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the pesticide and other agricultural chemicals market are Argentina, Australia, Austria, Bangladesh, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Iran, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, Ukraine, USA, and Vietnam. The pesticides and other agricultural chemicals market consists of the sales of rodenticides, liming and acidifying agents, soil conditioners, and chemicals used in animal husbandry. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pesticide and other agricultural chemicals market is segmented - 1) By Type: Herbicides, Insecticides, Fungicides, Other Pesticide and Other Agricultural Chemicals 2) By Origin: Synthetic, Bio-Based 3) By Application: Grains and Cereals, Pulses and Oilseeds, Commercial Crops, Fruits and Vegetables, Other Applications

The anti-infective drugs market consists of sales of branded and generic anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-infective drugs to treat microbial infections. The anti-infective drugs industry includes establishments that manufacture antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti-helminthic drugs to kill internal parasites, and antiprotozoal agents to treat protozoan infections. The main types of anti-infective drugs are antibiotics, antivirals, antifungals and others (anthelminthic, antiprotozoal). Antibiotics are drugs that either kill or slow the growth of bacteria. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others. The global anti-infective drugs market size is expected to decline from $220.0 billion in 2021 to $246.80 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The change in the anti-infective drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The anti-infective drugs market is expected to reach $614.29 billion in 2026 at a CAGR of 25.6%. The anti-infective drugs market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Another area of development is physiology-simulation modelling, in which the integrated physiology of the human organism, in both health and disease, is simulated through a computer program. Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early stages of the drug discovery process that are operational within hours, whereas traditional models take weeks to conduct simulations. The wide adoption of these technologies is expected to drive the anti-infective drugs market in the forecast period. The anti-infective drugs market is expected to be restrained by the increasing number of antimicrobial resistance cases due to growing ineffectiveness of conventional anti-infective drugs such as penicillin. Antimicrobial resistance is the final stage of the adaptation process of microorganisms such as bacteria to the environment developing the ability to resist the effects of anti-infective drugs. This is mainly caused by the overuse and misuse of anti-infective drugs such as antibiotics. The excessive use and misuse of anti-infective drugs increases the rate of the bacteria’s resistance, with an estimated 70% of bacteria ever discovered already being resistant to at least one anti-infective drug which was commonly used to treat them in the past. It is expected that deaths caused by antimicrobial resistance will rise to 10 million deaths by 2050. Increasing incidences of bacteria’s resistance to anti-infective drugs are expected to limit the use of anti-infective drugs, affecting the market’s growth. Anti-infective drug manufacturers are investing in programs to develop drugs to treat drug resistant infections. Antimicrobial resistance is a serious concern to global public health as it resulted in long duration of illness, the requirement of additional tests and use of more expensive drugs. Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, parasites and fungi change and adapted to drugs when they are exposed to antimicrobial drugs such as antibiotics, antivirals, antifungals, anthelmintics and others. According to World Health Organization (WHO), globally 4, 80,000 people are being affected by multi-drug resistant TB each year and drug resistance is starting to complicate the treatment of malaria and HIV as well. Companies are investing in developing the new drug candidates to treat drug-resistant infections. For instance, in 2019, the antibacterial agents imipenem, cilastatin and relebactam combination, pretomanid, lefamulin, and cefiderocol was approved by the US FDA in the field of resistant bacteria treatment for specific indications. Major companies in the anti-infective drugs market include Gilead Sciences, GlaxosmithKline, Merck & Co, Johnson & Johnson, Pfizer Inc., AbbVie, Bayer AG, Mylan N.V., Shionogi and F. Hoffmann-La Roche Ltd. North America was the largest region in the anti-infective drugs in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the anti-infective drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The global anti-infective drugs market is segmented - 1) By Type: Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal) 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others 3) By Route of Administration: Oral, Parenteral, Others 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs